Chanan Morris

Mr. Morris is a result-oriented manager with over 30 years of experience as a CFO in privately and publicly traded enterprises. He has vast experience in international negotiations, staff management, finance and operations and possesses strong leadership, analytical and planning skills.

Chanan has served as CFO of U.S. publicly traded companies including Artemis Therapeutics Inc (ATMS) and Galmed Pharmaceuticals Ltd. (GLMD), where he oversaw the successfully completed in 2014 Nasdaq initial public offering, raising USD 38 million. Chanan has worked extensively with the Infinity Venture Capital Group and managed a number of the group’s portfolio companies, in the United States, China and Israel. He has served in CEO, CFO, COO and Director roles. Chanan also is the CFO of IMED Infinity Medical, Limited Partnership (TASE: IMED).

Chanan received his Bsc in Accounting from Northeastern University (USA).